References
- Liu SP, Huang X, Ke GH, Huang XW. 3D radiation therapy or intensity-modulated radiotherapy for recurrent and metastatic cervical cancer: the Shanghai Cancer Hospital Experience. PLoS ONE 7(6), e40299 (2012).
- Sommers GM, Grigsby PW, Perez CA et al. Outcome of recurrent cervical carcinoma following definitive irradiation. Gynecol. Oncol. 35(2), 150–155 (1989).
- Thomas GM, Dembo AJ, Black B et al. Concurrent radiation and chemotherapy for carcinoma of the cervix recurrent after radical surgery. Gynecol. Oncol. 27(3), 254–263 (1987).
- Grigsby PW. Radiotherapy for pelvic recurrence after radical hysterectomy for cervical cancer. Radiat. Med. 23(5), 327–330 (2005).
- Zighelboim I, Taylor NP, Powell MA et al. Outcomes in 24 selected patients with stage IVB cervical cancer and excellent performance status treated with radiotherapy and chemotherapy. Radiat. Med. 24(9), 625–630 (2006).
- Coleman RL, Keeney ED, Freedman RS, Burke TW, Eifel PJ, Rutledge FN. Radical hysterectomy for recurrent carcinoma of the uterine cervix after radiotherapy. Gynecol. Oncol. 55(1), 29–35 (1994).
- Puthawala AA, Syed AM, Fleming PA, DiSaia PJ. Re-irradiation with interstitial implant for recurrent pelvic malignancies. Cancer 50(12), 2810–2814 (1982).
- Moore DH, Blessing JA, McQuellon RP et al. Phase III study of cisplatin with or without paclitaxel in stage IVB, recurrent, or persistent squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study. J. Clin. Oncol. 22(15), 3113–3119 (2004).
- Long HJ 3rd, Bundy BN, Grendys EC Jr et al.; Gynecologic Oncology Group Study. Randomized Phase III trial of cisplatin with or without topotecan in carcinoma of the uterine cervix: a Gynecologic Oncology Group Study. J. Clin. Oncol. 23(21), 4626–4633 (2005).
- Monk BJ, Sill MW, McMeekin DS et al. Phase III trial of four cisplatin-containing doublet combinations in stage IVB, recurrent, or persistent cervical carcinoma: a Gynecologic Oncology Group study. J. Clin. Oncol. 27(28), 4649–4655 (2009).
- Kitagawa R, Katsumata N, Shibata T et al. A randomized, Phase III trial of paclitaxel plus carboplatin (TC) versus paclitaxel plus cisplatin (TP) in stage IVb, persistent or recurrent cervical cancer: Japan Clinical Oncology Group study (JCOG0505). J. Clin. Oncol. 30 (2012) (Abstract 5006).